3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Neoplasms
2
Melanoma
2
Hematologic Neoplasms
2
Febrile Neutropenia
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neutropenia
1
Neoplasm Metastasis
1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Liver Neoplasms
1
Hematologic Diseases
1
Early Stage Non-Small Cell Lung Cancer
1
Clostridium Infections
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
49
fludarabine
36
Dexamethasone
35
venetoclax
29
pembrolizumab
26
Rituximab
21
Lenalidomide
18
pomalidomide
17
Gemcitabine
17
fludarabine phosphate
15
Etoposide
14
Cytarabine
13
daratumumab
11
carfilzomib
11
Temozolomide
11
Cisplatin
10
Calcium Dobesilate
10
glofitamab
9
Nivolumab
9
Injections
9
Azacitidine
9
selinexor
8
Vincristine
8
Carboplatin
8
Bortezomib
8
obinutuzumab
7
Immunotherapy, Adoptive
7
Bevacizumab
7
zanubrutinib
6
ruxolitinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Vancomycin
×
1 year
×
Clear all
No trials found.